AAPL   323.63 (+0.09%)
MSFT   184.42 (-0.26%)
FB   230.47 (-0.97%)
GOOGL   1,443.06 (+0.05%)
AMZN   2,469.67 (-0.11%)
NVDA   353.91 (+0.25%)
BABA   216.65 (+1.08%)
MU   48.01 (+2.54%)
TSLA   880.84 (-0.08%)
AMD   52.97 (-1.06%)
T   31.50 (+1.65%)
ACB   14.52 (-0.07%)
F   5.94 (+0.68%)
GILD   73.65 (+0.53%)
DIS   119.40 (+0.55%)
NFLX   422.63 (-1.10%)
BAC   25.49 (+2.62%)
BA   156.41 (+2.02%)
AAPL   323.63 (+0.09%)
MSFT   184.42 (-0.26%)
FB   230.47 (-0.97%)
GOOGL   1,443.06 (+0.05%)
AMZN   2,469.67 (-0.11%)
NVDA   353.91 (+0.25%)
BABA   216.65 (+1.08%)
MU   48.01 (+2.54%)
TSLA   880.84 (-0.08%)
AMD   52.97 (-1.06%)
T   31.50 (+1.65%)
ACB   14.52 (-0.07%)
F   5.94 (+0.68%)
GILD   73.65 (+0.53%)
DIS   119.40 (+0.55%)
NFLX   422.63 (-1.10%)
BAC   25.49 (+2.62%)
BA   156.41 (+2.02%)
AAPL   323.63 (+0.09%)
MSFT   184.42 (-0.26%)
FB   230.47 (-0.97%)
GOOGL   1,443.06 (+0.05%)
AMZN   2,469.67 (-0.11%)
NVDA   353.91 (+0.25%)
BABA   216.65 (+1.08%)
MU   48.01 (+2.54%)
TSLA   880.84 (-0.08%)
AMD   52.97 (-1.06%)
T   31.50 (+1.65%)
ACB   14.52 (-0.07%)
F   5.94 (+0.68%)
GILD   73.65 (+0.53%)
DIS   119.40 (+0.55%)
NFLX   422.63 (-1.10%)
BAC   25.49 (+2.62%)
BA   156.41 (+2.02%)
AAPL   323.63 (+0.09%)
MSFT   184.42 (-0.26%)
FB   230.47 (-0.97%)
GOOGL   1,443.06 (+0.05%)
AMZN   2,469.67 (-0.11%)
NVDA   353.91 (+0.25%)
BABA   216.65 (+1.08%)
MU   48.01 (+2.54%)
TSLA   880.84 (-0.08%)
AMD   52.97 (-1.06%)
T   31.50 (+1.65%)
ACB   14.52 (-0.07%)
F   5.94 (+0.68%)
GILD   73.65 (+0.53%)
DIS   119.40 (+0.55%)
NFLX   422.63 (-1.10%)
BAC   25.49 (+2.62%)
BA   156.41 (+2.02%)
Log in

LON:N4PN4 Pharma Price Target & Analyst Ratings

GBX 4.84
-0.06 (-1.23 %)
(As of 06/3/2020 06:22 AM ET)
Add
Compare
Today's Range
4.80
Now: GBX 4.84
4.94
50-Day Range
4.75
MA: GBX 5.74
7.20
52-Week Range
2
Now: GBX 4.84
7.90
Volume500,206 shs
Average Volume1.76 million shs
Market Capitalization£7.36 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

N4 Pharma (LON:N4P) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/5/2018Beaufort SecuritiesReiterated RatingSpeculative Buy
(Data available from 6/3/2018 forward)
This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.